ERA Biotech, a Barcelona, Spain-based company focused on improving the manufacturing of of recombinant proteins in cultured cellshas raised Euro 1.4 million in convertible note funding. Participants included Invertec, Reus Capital Riesgo, Talde Capial II and Uninvest. www.erabiotech.com
ConjuGon Inc., a Madison, Wis.-based drug company focused on the treatment of antibiotic resistant bacterial infections, has raised $3.3 million in VC funding. Rosetta Partners led the deal, and was joined by returning angel backer Wisconsin Investment Partners. www.conjugon.com
MEDecision Inc., a Wayne, Pa.-based provider of medical management solutions to healthcare payers and regional health information organizations, priced 4.7 million common shares at $10 per share, for an IPO take of approximately $47 million. This comes in below an already-reduced forecast of 5.5 million shares at between $11.50 and $13.50 per share. It will […]
NewStar Financial Inc., a Boston-based provider of debt financing for middle-market businesses, priced 12 million common shares at $17 per share ($15-$17 range), for an IPO take of approximately $204 million. It will trade on the Nasdaq under ticker symbol NEWS, while underwriters included Goldman Sachs, Morgan Stanley, Citigroup and Wachovia Securities. Shareholders include Capital […]
Obagi Medical Products Inc., a Long Beach, Calif.-based pharma company focused on the aesthetic and therapeutic skin health markets, priced 5.35 million common shares at $11 per share ($13-$15 forecast), for an IPO take of approximately $58.9 million. It will trade on the Nasdaq under ticker symbol OMPI, whiled JPMorgan served as lead underwriter. Stonginton […]
Venda Ltd., a London-based provider of managed ecommerce and CRM solutions, has raised $20 million in Series A funding. Investor Growth Capital led the deal, and was joined by returning seed backer GF Private Equity Group. www.venda.com
Oncogenex Technologies Inc., a Vancouver-based drug company focused on cancer therapeutics, has filed for a $48 million IPO. It plans to trade on both the Nasdaq and TSX, with RBC Capital Markets serving as lead underwriter. Shareholders include Ventures West, BDC Venture Capital, GrowthWorks, HIG Capital and Milestone Medica Corp. www.oncogenex.ca
World Energy Labs, a San Francisco
Softscope Medical Technologies Inc., a St. Louis Park, Minn.-based developer of medical devices to improve endoscopic procedures, has raised $4 million in Series A funding co-led by Thomas McNerney & Partners and Accuitive Medical Ventures. www.softscopemed.com
GroSolar, a White River Junction, Vt.